Explore the details of the Celgene Corporation V. Natco Pharma Limited case under case number 1:23-cv-01019 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.
The following parties are involved in this case, with their respective legal representatives for the case.
| Name | Represented By |
|---|---|
| Natco Pharma Limited | - |
| Celgene International Sarl | - |
| Bristol-Myers Squibb Company | - |
Patents not found - set an alert to get notified when patents are added.
The Docket Entries section provides a chronological list of all significant filings and court actions in this case.
| Date | Docket Entry | Type |
|---|---|---|
Set alerts for critical docket entry | ||
| Feb 13, 2024 | PROPOSED Scheduling Order, by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Attachments: # 1 Letter to The Honorable Jennifer L. Hall)(Farnan, Michael) Modified on 2/13/2024 (ceg). (Entered: 02/13/2024) | PACER Document |
| Feb 20, 2024 | Letter to The Honorable Judge Jennifer L. Hall from Nathan R. Hoeschen regarding Rule 16 conference set for February 23, 2024. (Hoeschen, Nathan) Modified on 2/21/2024 (ceg). (Entered: 02/20/2024) | PACER Document |
| Feb 23, 2024 | SCHEDULING AND CONSOLIDATION ORDER: Celgene Corporation v. Teva Pharmaceuticals, Inc., C.A. No. 1:23-cv-01008-JLH, and Celgene Corporation v. Natco Pharma Ltd., C.A. No. 1:23-cv-01019-JLH, are consolidated for all purposes up to and including trial. Joinder of Parties due by 8/23/2024. Amended Pleadings due by 8/23/2024. Status Report due by 10/23/2024. Fact Discovery completed by 4/4/2025. Expert Discovery due by 10/13/2025. Joint Claim Construction Brief due by 10/14/2024. A Markman Hearing is set for 1/9/2025 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. Proposed Pretrial Order due by 2/16/2026. A Pretrial Conference is set for 2/23/2026 at 03:00 PM in Courtroom 6D before Judge Jennifer L. Hall. A 3-day Bench Trial is set for 3/2/2026 at 09:30 AM in Courtroom 6D before Judge Jennifer L. Hall. (*See Order for details). Signed by Judge Jennifer L. Hall on 2/23/2024. Associated Cases: 1:23-cv-01008-JLH, 1:23-cv-01019-JLH(ceg) (Entered: 02/23/2024) | PACER Document |
| Sep 20, 2023 | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) | PACER Document |
| Sep 20, 2023 | SO ORDERED, re 8 MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Heather M. Petruzzi, Andrew J. Danford, Nora Q.E. Passamaneck, David Mlaver, Gerard A. Salvatore, and Li-tsung Alyssa Chen, filed by Celgene Corporation, Celgene International Sarl, Bristol-Myers Squibb Company. Signed by Judge Richard G. Andrews on 9/20/2023. (nms) | PACER Document |
| Sep 27, 2023 | Pro Hac Vice Attorney Heather M. Petruzzi, Amy K. Wigmore, Gerard A. Salvatore, Nora Q.E. Passamaneck, Andrew J. Danford, and Li-tsung A. Chen for Celgene Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-01008-RGA, 1:23-cv-01019-RGA(mpb) | PACER Document |
| Sep 27, 2023 | Pro Hac Vice Attorney David Mlaver for Celgene Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-01008-RGA, 1:23-cv-01019-RGA(mpb) | PACER Document |
| Nov 14, 2023 | SO ORDERED, re 9 UNOPPOSED Motion to Extend Time to Respond to Complaint (*Reset Answer Deadlines: Natco Pharma Limited answer due 12/20/2023). Signed by Judge Richard G. Andrews on 11/14/2023. (nms) | PACER Document |
| Jan 11, 2024 | Pro Hac Vice Fee - Credit Card Payment received for Christopher J. Sorenson, Andrew O. Larsen, and Jason Wiener. ( re 12 MOTION for Pro Hac Vice Appearance of Attorney Christopher J. Sorenson, 13 MOTION for Pro Hac Vice Appearance of Attorney Andrew O. Larson, 14 MOTION for Pro Hac Vice Appearance of Attorney Jason Wiener )( Payment of $ 150, receipt number ADEDC-4312498).(Green, James) (Entered: 01/11/2024) | PACER Document |
| Jan 11, 2024 | SO ORDERED, re 12 MOTION for Pro Hac Vice Appearance of Attorney Christopher J. Sorenson, filed by Natco Pharma Limited, 13 MOTION for Pro Hac Vice Appearance of Attorney Andrew O. Larson, filed by Natco Pharma Limited, and 14 MOTION for Pro Hac Vice Appearance of Attorney Jason Wiener, filed by Natco Pharma Limited. Signed by Judge Richard G. Andrews on 1/11/2024. (nms) | PACER Document |
| Jan 16, 2024 | Case Reassigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. Associated Cases: 1:21-cv-01795-RGA, 1:23-cv-00699-RGA, 1:23-cv-01008-RGA, 1:23-cv-01019-RGA(nms) | PACER Document |
| Jan 18, 2024 | Pro Hac Vice Attorney Christopher J. Sorenson,Andrew O. Larsen,Jason M. Wiener for Natco Pharma Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) | PACER Document |
| Jan 22, 2024 | ORAL ORDER: IT IS HEREBY ORDERED that the Scheduling Conference scheduled for February 5, 2024 is RESCHEDULED February 23, 2024 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. Ordered by Judge Jennifer L. Hall on 1/22/2024. Associated Cases: 1:23-cv-01008-JLH, 1:23-cv-01019-JLH(ceg) | PACER Document |
| Feb 21, 2024 | ORAL ORDER: The Rule 16(b) Conference scheduled for February 23, 2024 is CANCELLED. Ordered by Judge Jennifer L. Hall on 2/21/2024. Associated Cases: 1:23-cv-01008-JLH, 1:23-cv-01019-JLH(ceg) (Entered: 02/21/2024) | PACER Document |
| Feb 23, 2024 | Case associated with lead case: Create association to 1:23-cv-01008-JLH. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 1:23-cv-01008-JLH ONLY. (ceg) | PACER Document |
| Nov 14, 2023 | UNOPPOSED Motion to Extend Time to Respond to Complaint - filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Attachments: # 1 Proposed Order)(Farnan, Michael) Modified on 11/14/2023 (nms). (Entered: 11/14/2023) | Attachment |